IBRX

IMMUNITYBIO INC

Healthcare | Mid Cap

-$0.08

EPS Forecast

$42.58

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-01

Proximilar's AI forecasts

EPS Forecast:

-$0.08

Revenue Forecast:

$42.58

EPS Surprise Forecast:

$0.003

Revenue Surprise Forecast:

$2

Post-release price volatility - Very high

Post-release Overnight Move:

±10.5%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

56%

Probability of beating revenue consensus:

55%

Probability of beating both EPS & revs consensus:

37%

Probability of missing both EPS & revs consensus:

25%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-5

Beta (β)

Forward Looking Beta (β):

1.94

Earnings volatility

EPS standard deviation:

$0.08

Revenue standard deviation:

$35

As % of share price:

0.88% VERY HIGH

As % of market cap:

0.39% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

$0.03

Revenue 95th %ile:

$91

EPS 75th %ile:

-$0.05

Revenue 75th %ile:

$56

EPS 25th %ile:

-$0.10

Revenue 25th %ile:

$31

EPS 5th %ile:

-$0.16

Revenue 5th %ile:

$3

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

37% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

83% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$10

Bid-ask per Share:

$0.01